OurPet’s, Inc. is a U.S.-based subsidiary of South Korea’s OurPet’s Co., Ltd., specializing in the research, development and manufacture of veterinary pharmaceuticals and nutraceuticals. The company focuses on creating innovative health solutions for companion animals and livestock, offering a range of prescription and over-the-counter products designed to support animal wellness and disease management. Headquartered in Meridian, Idaho, OurPet’s operates under a quality system aligned with global regulatory standards, ensuring consistency and safety in its production processes.
The company’s product portfolio encompasses antibiotics, antiparasitics, anti-inflammatories, nutritional supplements and probiotics. These offerings address common veterinary needs such as digestive health, respiratory care, skin conditions and metabolic support. OurPet’s also provides feed additives and performance enhancers for livestock, working closely with veterinarians, feedlot operators and distributors to tailor solutions that improve herd health and productivity. Its in-house formulation and analytical capabilities enable rapid development of new compounds and dosage forms.
OurPet’s distributes its products across North America and maintains strategic partnerships in Asia and Europe to support international expansion. The leadership team combines expertise in veterinary science, pharmaceutical manufacturing and global regulatory affairs to guide the company’s growth initiatives. By investing in research collaborations and advanced manufacturing technologies, OurPet’s aims to broaden its therapeutic portfolio and strengthen its position as a trusted supplier of animal health products.
AI Generated. May Contain Errors.
